By Gilang Cahya 
In a significant breakthrough that could illuminate one of modern medicine’s most perplexing trends, an international consortium of scientists, spearheaded by researchers at the University of California San Diego (UC San Diego), has pinpointed a likely microbial agent behind the escalating rates of early-onset colorectal cancer: a potent bacterial toxin known as colibactin. This discovery offers a compelling explanation for why individuals are increasingly being diagnosed with this aggressive form of cancer at younger ages, often before the age of 50, a phenomenon that has baffled medical professionals for years.
The research, published on April 23rd in the prestigious scientific journal Nature, reveals that colibactin, produced by specific strains of Escherichia coli bacteria that naturally inhabit the colon and rectum, possesses the insidious ability to directly damage DNA. The study’s groundbreaking findings demonstrate that exposure to this toxin, particularly during early childhood, leaves a distinct and enduring genetic signature on colon cells. This signature, characterized by a unique pattern of DNA mutations, appears to significantly elevate an individual’s predisposition to developing colorectal cancer at a much earlier stage of life.
Unraveling the Genetic Fingerprint of Colibactin
The comprehensive analysis, which formed the backbone of this pivotal study, meticulously examined the genomes of 981 colorectal cancer patients. These individuals spanned a wide spectrum of ages at diagnosis, encompassing both early-onset (under 50) and late-onset (over 70) cases, and hailed from 11 countries with diverse colorectal cancer incidence rates. The results were striking: the tell-tale patterns of DNA mutations linked to colibactin were found to be a staggering 3.3 times more prevalent in early-onset cases, specifically among adults under 40, when compared to their older counterparts diagnosed after the age of 70. Furthermore, these mutation patterns exhibited a pronounced correlation with countries that experience a higher incidence of early-onset colorectal cancer.
"These mutation patterns act as a historical record etched within the genome, and they strongly implicate early-life exposure to colibactin as a primary driving force behind the development of early-onset disease," stated Ludmil Alexandrov, a senior author of the study and a professor in the Shu Chien-Gene Lay Department of Bioengineering and the Department of Cellular and Molecular Medicine at UC San Diego. Professor Alexandrov, who is also affiliated with the UC San Diego Moores Cancer Center and serves as the Deputy Director of the Sanford Stem Cell Fitness and Space Medicine Center, emphasized the significance of this genomic evidence.
A Growing Epidemic Among the Young
The implications of these findings are profound and deeply concerning. Colorectal cancer, once predominantly a disease affecting older adults, has witnessed an alarming surge in incidence among younger populations across at least 27 countries. The rate of colorectal cancer in adults under the age of 50 has approximately doubled every decade for the past two decades. Projections indicate that if these trends persist, colorectal cancer is poised to become the leading cause of cancer-related mortality among young adults by the year 2030, a stark testament to the escalating public health crisis.
Until this recent research, the underlying reasons for this burgeoning epidemic remained largely elusive. Young adults diagnosed with colorectal cancer often present without a discernible family history of the disease and exhibit few of the traditionally recognized risk factors, such as obesity or hypertension. This lack of clear etiology has fueled intense speculation regarding the role of potential, yet unidentified, environmental or microbial exposures – a hypothesis that this new study directly and compellingly addresses.
The Unexpected Trajectory of Discovery
The genesis of this research was not initially focused on early-onset colorectal cancer. "When we embarked on this project, our intention was not specifically to investigate early-onset colorectal cancer," explained Marcos Díaz-Gay, a co-first author of the study and a former postdoctoral researcher in Professor Alexandrov’s laboratory. "Our initial objective was to analyze global patterns of colorectal cancer to comprehend the disparities in incidence rates among different nations. However, as we delved deeper into the data, one of the most compelling and unexpected discoveries was the remarkably high frequency of colibactin-related mutations in the early-onset cases."
The team’s meticulous molecular timing of the identified mutational signatures revealed that colibactin’s damaging effects commence early in the tumor development process. This aligns with prior research suggesting that such mutations can occur within the first decade of life. Crucially, the study further established that colibactin-related mutations account for approximately 15% of the critical genetic alterations known as "APC driver mutations" – some of the earliest genetic changes that directly propel cancer development – in colorectal cancer.
"If an individual acquires one of these driver mutations by the age of 10," Professor Alexandrov elaborated, "they could be decades ahead of the typical timeline for developing colorectal cancer, potentially leading to a diagnosis at age 40 instead of the more common age of 60." This suggests a scenario where colibactin-producing bacteria may silently colonize children’s colons, initiating subtle but significant molecular alterations in their DNA and laying the groundwork for colorectal cancer long before any overt symptoms manifest.
While the evidence presented provides robust support for this hypothesis, Professor Alexandrov cautioned that further rigorous research is essential to definitively establish causality.
A Legacy of Decoding Cancer’s Genetic Signatures
This significant contribution is part of the ongoing work of the Cancer Grand Challenges team, Mutographs, which receives funding from Cancer Research UK. It represents the latest milestone in a cumulative body of research advanced by Professor Alexandrov, Dr. Díaz-Gay, and their colleagues over several years. Their expertise lies in deciphering the complex patterns of DNA mutations that arise from environmental exposures, such as ultraviolet radiation and bacterial toxins, as well as lifestyle choices like smoking and alcohol consumption. Each of these factors leaves a distinct genetic fingerprint on the genome, a unique mutational signature that can serve as a critical clue in identifying the origins of specific cancers.
As a result of a long-standing collaboration between UC San Diego, the International Agency for Research on Cancer (France), and the Wellcome Sanger Institute (UK), facilitated by Cancer Grand Challenges funding, the Mutographs team has successfully elucidated the mutational processes underlying various cancers, including esophageal, kidney, and head and neck cancers globally. This most recent discovery concerning colorectal cancer further expands the international scientific community’s understanding of cancer etiology through the sophisticated analysis of mutational signatures.
By systematically cataloging these intricate mutational patterns across thousands of cancer genomes, the researchers have been actively working to identify novel causes of cancer that have previously remained undetected or underestimated.
"Not every environmental factor or human behavior we investigate leaves a discernible mark on our genome," Professor Alexandrov noted. "However, we have found that colibactin is indeed one of those factors that can leave such an imprint. In this particular instance, its genetic signature appears to be strongly associated with colorectal cancers that develop in young adults."
Charting the Course for Future Research and Prevention
The team’s latest discovery opens a Pandora’s Box of new and critical questions. Foremost among these is how children are being exposed to colibactin-producing bacteria, and what effective strategies can be implemented to prevent or mitigate this exposure. Are there specific environmental conditions, dietary habits, or lifestyle choices that might predispose individuals to increased colibactin production? Furthermore, how can individuals ascertain if they have already acquired these cancer-promoting mutations?
The research team is actively pursuing several hypotheses to address these pressing questions. They are conducting further investigations to meticulously examine the correlation between colibactin and the risk of early-onset colorectal cancer. In parallel, they are exploring the potential therapeutic benefits of probiotics in safely eradicating harmful bacterial strains. A significant area of development also includes the creation of early detection tests that analyze stool samples for the presence of colibactin-related mutations, offering a non-invasive method for identifying individuals at heightened risk.
Meanwhile, the team continues its global endeavor to discover additional cancer-linked mutational signatures. The recent Nature publication also revealed that colorectal cancers originating from specific countries – notably Argentina, Brazil, Colombia, Russia, and Thailand – exhibited an increased prevalence of certain mutational signatures. This observation strongly suggests that localized environmental exposures may play a significant role in contributing to cancer risk within these regions.
"It is plausible that different countries harbor distinct, as yet unidentified, causes of cancer," commented Dr. Díaz-Gay, who is now spearheading a new phase of the study from his recently established laboratory at the Spanish National Cancer Research Center (CNIO) in Madrid, Spain. "This realization could pave the way for the development of targeted, region-specific prevention strategies."
Professor Alexandrov highlighted a broader, transformative implication of this research: that a substantial number of cancers may, in fact, originate from environmental or microbial exposures encountered during early life, long before any clinical diagnosis is made.
"This fundamentally reshapes our understanding of cancer," he concluded. "It suggests that cancer development may not solely be a consequence of events occurring in adulthood, but could potentially be influenced by events that transpire in early life, perhaps even within the first few years of existence. Sustained investment in this type of research is absolutely critical to the global effort to prevent and treat cancer effectively, before it becomes too late to intervene."
